What Is HCG? A Research Overview of the Peptide Hormone

Human chorionic gonadotropin, or HCG, is one of the most extensively characterized hormones in reproductive biology. Long before it became a staple reagent on research benches, HCG was studied for its role in early pregnancy — and that biological story is still what makes it useful to researchers today.

A Glycoprotein With a Distinct Structure

HCG is a 237-amino-acid heterodimer made up of two non-covalently linked subunits:

• An alpha subunit (roughly 92 amino acids) that HCG shares in common with three other pituitary hormones — LH, FSH, and TSH.
• A beta subunit (roughly 145 amino acids) that is unique to HCG and gives the molecule its specific biological activity.

The beta subunit is where HCG earns its distinct identity. It shares about 80–85% sequence homology with the beta subunit of luteinizing hormone (LH), but carries an additional 24-amino-acid stretch at its C-terminus found nowhere else in the glycoprotein hormone family. That extra sequence — often called the C-terminal peptide, or CTP — is part of why HCG behaves differently from LH in the body despite binding the same receptor.

Both subunits are heavily glycosylated, carrying a total of eight carbohydrate side chains. This glycosylation isn't incidental — it directly affects the molecule's stability, its half-life in circulation, and how strongly it binds its receptor, which is part of why HCG variants (regular HCG, hyperglycosylated HCG, and free beta subunit) are studied as distinct entities rather than a single interchangeable molecule.

Where It Comes From — and Where Research-Grade HCG Comes From

Naturally, HCG is produced primarily by syncytiotrophoblast cells of the placenta during early pregnancy, where it plays a central signaling role in maintaining the corpus luteum. Pharmaceutical and research-grade HCG, by contrast, is sourced one of two ways: purified from the urine of pregnant women, or produced recombinantly in cell culture systems. Recombinant production has become increasingly common in research settings because it allows for tighter batch-to-batch consistency and reduces the risk of co-purified biological contaminants — both of which matter when a molecule is going into a controlled experimental protocol.

Why HCG Shows Up Across So Many Fields of Research

Because HCG binds the same luteinizing hormone/chorionic gonadotropin receptor (LHCGR) that LH does, it has become a useful tool wherever researchers are studying that signaling pathway — not just in reproductive contexts. Published research has explored HCG's role in:

• Reproductive endocrinology — its interaction with LHCGR and downstream signaling cascades such as PKA, PKC, and Smad2.
• Angiogenesis and tissue signaling — its involvement in promoting blood vessel formation in uterine endothelial tissue.
• Immunomodulation — its documented role at the maternal-fetal interface, an area of interest for immunology researchers well outside of reproductive biology.
• Oncology-adjacent research — hyperglycosylated HCG's behavior as an autocrine factor in certain malignant cell lines has made it a molecule of interest in cancer biology.

That range is unusual for a single hormone, and it's a large part of why HCG remains a frequently requested reagent across research groups working in very different fields.

A Note on Research-Grade Material

Because HCG is a well-characterized, FDA-approved molecule in clinical contexts, there's an unusually deep body of published data on its structure, stability, and receptor behavior — which makes it a well-understood starting point for new experimental designs. Research-grade HCG from a reputable supplier should come with a certificate of analysis confirming purity, and is intended strictly for laboratory research use, not for human or veterinary administration.